When presented on the cell surface, the neoantigens can serve as the target of CD4+ helper T lymphocytes and CD8+ cytotoxic T lymphocytes (CTL) for tumour infiltration, thus enhancing the immunity to cancer and paving the way for immunotherapy targeting neoantigens21, 22 (Figure 2). The gene discussed is CD4; the disease is neoplasm.